NUR 600 Module 4 Assignment Draft of Script for PowerPoint Presentation
ST Thomas University NUR 600 Module 4 Assignment Draft of Script for PowerPoint Presentation– Step-By-Step Guide
This guide will demonstrate how to complete the ST Thomas University NUR 600 Module 4 Assignment Draft of Script for PowerPoint Presentation assignment based on general principles of academic writing. Here, we will show you the A, B, Cs of completing an academic paper, irrespective of the instructions. After guiding you through what to do, the guide will leave one or two sample essays at the end to highlight the various sections discussed below.
How to Research and Prepare for NUR 600 Module 4 Assignment Draft of Script for PowerPoint Presentation
Whether one passes or fails an academic assignment such as the ST Thomas University NUR 600 Module 4 Assignment Draft of Script for PowerPoint Presentation depends on the preparation done beforehand. The first thing to do once you receive an assignment is to quickly skim through the requirements. Once that is done, start going through the instructions one by one to clearly understand what the instructor wants. The most important thing here is to understand the required format—whether it is APA, MLA, Chicago, etc.
After understanding the requirements of the paper, the next phase is to gather relevant materials. The first place to start the research process is the weekly resources. Go through the resources provided in the instructions to determine which ones fit the assignment. After reviewing the provided resources, use the university library to search for additional resources. After gathering sufficient and necessary resources, you are now ready to start drafting your paper.
How to Write the Introduction for NUR 600 Module 4 Assignment Draft of Script for PowerPoint Presentation
The introduction for the ST Thomas University NUR 600 Module 4 Assignment Draft of Script for PowerPoint Presentation is where you tell the instructor what your paper will encompass. In three to four statements, highlight the important points that will form the basis of your paper. Here, you can include statistics to show the importance of the topic you will be discussing. At the end of the introduction, write a clear purpose statement outlining what exactly will be contained in the paper. This statement will start with “The purpose of this paper…” and then proceed to outline the various sections of the instructions.
Need a high-quality paper urgently?
We can deliver within hours.
How to Write the Body for NUR 600 Module 4 Assignment Draft of Script for PowerPoint Presentation
After the introduction, move into the main part of the NUR 600 Module 4 Assignment Draft of Script for PowerPoint Presentation assignment, which is the body. Given that the paper you will be writing is not experimental, the way you organize the headings and subheadings of your paper is critically important. In some cases, you might have to use more subheadings to properly organize the assignment. The organization will depend on the rubric provided. Carefully examine the rubric, as it will contain all the detailed requirements of the assignment. Sometimes, the rubric will have information that the normal instructions lack.
Another important factor to consider at this point is how to do citations. In-text citations are fundamental as they support the arguments and points you make in the paper. At this point, the resources gathered at the beginning will come in handy. Integrating the ideas of the authors with your own will ensure that you produce a comprehensive paper. Also, follow the given citation format. In most cases, APA 7 is the preferred format for nursing assignments.
How to Write the Conclusion for NUR 600 Module 4 Assignment Draft of Script for PowerPoint Presentation
After completing the main sections, write the conclusion of your paper. The conclusion is a summary of the main points you made in your paper. However, you need to rewrite the points and not simply copy and paste them. By restating the points from each subheading, you will provide a nuanced overview of the assignment to the reader.
How to Format the References List for NUR 600 Module 4 Assignment Draft of Script for PowerPoint Presentation
The very last part of your paper involves listing the sources used in your paper. These sources should be listed in alphabetical order and double-spaced. Additionally, use a hanging indent for each source that appears in this list. Lastly, only the sources cited within the body of the paper should appear here.
Stuck? Let Us Help You
Completing assignments can sometimes be overwhelming, especially with the multitude of academic and personal responsibilities you may have. If you find yourself stuck or unsure at any point in the process, don’t hesitate to reach out for professional assistance. Our assignment writing services are designed to help you achieve your academic goals with ease.
Our team of experienced writers is well-versed in academic writing and familiar with the specific requirements of the NUR 600 Module 4 Assignment Draft of Script for PowerPoint Presentation assignment. We can provide you with personalized support, ensuring your assignment is well-researched, properly formatted, and thoroughly edited. Get a feel of the quality we guarantee – ORDER NOW.
Sample Answer for NUR 600 Module 4 Assignment Draft of Script for PowerPoint Presentation
Draft of Script for PowerPoint Presentation
Slide 1: Introduction
Greetings everyone. My name is ___, and I welcome you to this presentation on Gabapentin. There are generic and brand versions of gabapentin available. Gabapentin is the generic name for it. Gabapentin is marketed under the brand names Neurontin, Horizant, and Gralise (Pauly et al., 2020).
Slide 2: Drug Pharmacology
Gabapentin belongs to a category of drugs known as anticonvulsants. Gabapentin mitigates seizures by reducing aberrant neuronal hyperactivity in the brain. Gabapentin alleviates postherpetic neuralgia (PHN) by modulating the body’s pain perception. The mechanism by which gabapentin effectively treats restless legs syndrome remains unclear. The therapeutic effects of gabapentin primarily target the α2δ-1 subunit of voltage-gated calcium channels. This subunit plays a crucial role in facilitating the movement of pore-forming calcium channels (Pauly et al., 2020).
Slide 3: Pharmacodynamics
Gabapentin is an anticonvulsant drug that works by blocking the activity of excitatory neurotransmitters. It is beneficial in treating conditions involving abnormal neurotransmission, such as neuropathic pain and seizure disorders. Although it has a broad therapeutic range, it is not practical in treating absence seizures and has been linked to possibly deadly multi-organ hypersensitivity (Horne et al., 2020).
Slide 4: Pharmacokinetics
Gabapentin is a medication absorbed by the intestines via an amino acid transporter known as LAT2. The pharmacokinetics of this substance vary based on the dosage, resulting in reduced bioavailability and delayed peak levels when higher doses are administered. The oral bioavailability of this compound is approximately 80% at a dosage of 100 mg, but it tends to decrease at higher doses (Horne et al., 2020). Gabapentin can penetrate the blood-brain barrier and access the central nervous system.
Slide 5: Dosing Indications For Use
Gabapentin is a medication that is prescribed for a range of conditions. The recommended dosage typically begins at 300 mg daily and can be gradually increased to a maximum of 4800 mg (Russo et al., 2022). The effects of this treatment typically show improvement within a week, although it may take up to a month to see significant results.
Slide 6: Side Effects
According to Hong et al. (2021), gabapentin may cause severe side effects such as erythema multiforme, anaphylaxis, depression, suicidality, and withdrawal symptoms. Ataxia, lightheadedness, exhaustion, nystagmus, and vomiting are typical side effects.
ALSO READ:
NUR 600 Discussion 5.1 Lung Diagnoses
NUR 600 Module 4 Discussion Treatments for Respiratory Disorders
NUR 600 Discussion 6.1 Cardiovascular Diagnoses
NUR 600 Discussion 6.1 Cardiovascular Diagnoses Responses
NUR 600 Discussion 9.1 Patient Comfort During Genital Exams
NUR 600 Assignment 9.1 Iatrogenic Hymenal Case Study Write-Up
NUR 600 Discussion 10.1 Musculoskeletal System Diagnoses
NUR 600 Assignment 10.2 Musculoskeletal and Neurological Write-Up
NUR 600 Discussion 11.1 Crucial Conversations
NUR 600 Assignment 11.2 Writing a SOAP Note
Slide 7: Contraindications
Specific individuals who have a history of allergic reactions, misuse, pregnancy, a sodium/potassium diet, kidney problems, or other health conditions may not be appropriate candidates for gabapentin (Hong et al., 2021).
Slide 8: Pregnancy Class
Gabapentin is classified as a pregnancy category B3 drug by AU TGA. This category is assigned to drugs that are used by a limited number of pregnant and childbearing women, with no reported increase in fetal malformation or harmful effects (Evoy et al., 2020).
Slide 9: Cost Analysis Of The Drug
The cost of Gabapentin is contingent upon pharmacy, treatment plan, insurance, and formulation. Postherpetic neuralgia and partial seizures are within its approved indications (Evoy et al., 2020). Three-month supplies, mail-order pharmacies, or generic alternatives can help reduce long-term expenses.
Slide 10: Patient Case Study
A 59-year-old woman of Caucasian descent, who has a medical background of major depressive disorder and generalized anxiety disorder (GAD), has been admitted to the hospital multiple times due to her condition. She has also experienced thoughts of self-harm and has recently been prescribed gabapentin to help alleviate withdrawal symptoms.
Slide 11: Patient Education
Offer comprehensive information to patients about gabapentin, encompassing its advantages, potential adverse effects, and proper administration methods. It is essential to provide information on possible side effects, exercise caution, and emphasize safety measures such as handrails and assistive devices to prevent falls (Evoy et al., 2020).
Slide 12: Nurse Practitioner Role
Nursing practitioners prioritize patient care by addressing various aspects of gabapentin treatment, including dosage, schedule, education, safety measures, pain management, and emotional support. They also emphasize the importance of caution, safety measures, and mental health support when necessary (Rissardo et al., 2023).
Slide 13: Monitoring and Follow-Up
Monitoring gabapentin treatment requires assessing baseline creatinine levels before and during therapy, providing patients with information, and conducting screenings for depression, behavioral changes, and suicidality (Rissardo et al., 2023). Follow-up for the patient was scheduled in two weeks to monitor treatment outcomes.
Slide 14: References
Evoy, K. E., Sadrameli, S., Contreras, J., Covvey, J. R., Peckham, A. M., & Morrison, M. D. (2020). Abuse and misuse of pregabalin and gabapentin: a systematic review update. Drugs, 81(1), 125–156. https://doi.org/10.1007/s40265-020-01432-7
Hong, J. S. W., Atkinson, L. Z., Al‐Juffali, N., Awad, A., Geddes, J., Tunbridge, E. M., Harrison, P. J., & Cipriani, A. (2021). Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale. Molecular Psychiatry, 27(3), 1339–1349. https://doi.org/10.1038/s41380-021-01386-6
Horne, A., Vincent, K., Hewitt, C., Middleton, L., Koscielniak, M., Szubert, W., Doust, A., & Daniels, J. (2020). Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomized, double-blind, placebo-controlled trial. Lancet (British Edition), 396(10255), 909–917. https://doi.org/10.1016/s0140-6736(20)31693-7
Pauly, N., Delcher, C., Slavova, S., Lindahl, E., Talbert, J., & Freeman, P. R. (2020). Trends in gabapentin prescribing in a commercially insured U.S. adult population, 2009-2016. Journal of Managed Care & Specialty Pharmacy, 26(3), 246–252. https://doi.org/10.18553/jmcp.2020.26.3.246
Rissardo, J. P., De Matos, U. M. A., & Caprara, A. L. F. (2023). Gabapentin-associated movement disorders: a literature review. Medicines, 10(9), 52. https://doi.org/10.3390/medicines10090052
Russo, M., Graham, B. A., & Santarelli, D. M. (2022). Gabapentin—Friend or foe? Pain Practice (Print), 23(1), 63–69. https://doi.org/10.1111/papr.13165